Price Move History
- Daily moves over 5%
- 108 207 sessions, August 19, 2025 to August 20, 2026
- Largest daily move
- +95.3% close of March 20, 2026
- 1-year change
- +229.4% closing prices, August 19, 2025 to August 20, 2026
- 1-month change
- -17.7% closing prices, July 16, 2026 to August 20, 2026
Company Description
Mountain Valley MD Holdings Inc. (trading over-the-counter under the symbol MVMDF) is a biotechnology-focused company centered on the implementation, licensing, and reselling of key health and agricultural technologies and formulations. Across its disclosures, the company describes three core business lines: nutraceuticals powered by its patented Quicksome™ oral formulation and delivery technologies, husbandry animal and aquatic applications using its patented Quicksol™ solubility formulation technology, and agricultural solutions as a licensed product reseller of Agrarius™, a plant signaling technology designed to support crop performance.
Core Technologies and Business Model
Mountain Valley MD states that it is building its organization around owned and licensed technologies that can be implemented, licensed, and resold rather than relying on in-house large-scale manufacturing. In its public updates, the company highlights three primary technology pillars:
- Quicksome™ oral formulation and delivery technologies – patented liposomal formulations and stabilizing molecules intended to encapsulate active ingredients and optimize delivery in sublingual nutraceutical formats. The company describes Quicksome™ as focusing on applications where enhanced efficacy, precise dosing, reduced variability, and dose sparing are valued.
- Quicksol™ solubility formulation technology – a patented technology covering highly solubilized macrocyclic lactones, which the company indicates can be applied to drug formulations such as ivermectin. Mountain Valley MD reports that Quicksol™-based formulations are designed to improve solubility, bioavailability, and stability for human and animal health applications.
- Agrarius™ agricultural plant signaling technology – a licensed, certified organic product that the company describes as a plant signaling technology applied to crops to naturally increase yields, reduce fertilizer usage where desired, and enhance resilience to pests and climate-related stress.
According to multiple company news releases, Mountain Valley MD’s business activities emphasize implementation and licensing of these platforms to partners, along with reselling of licensed agricultural products within defined territories.
Nutraceuticals and Quicksome™ Platform
In its nutraceutical line of business, Mountain Valley MD reports that its Quicksome™ technology is used to formulate sublingual rapid-dissolve tablets and powders. The company describes Quicksome™ as using proprietary formulations and stabilizing agents to encapsulate active ingredients, with the goal of delivering molecules into the body faster and with greater impact and efficiency than conventional orally consumed products.
The company has disclosed a licensing and manufacturing structure in which a U.S.-based GMP production partner (referred to as the “Lead Manufacturer”) produces Quicksome™-based nutraceutical products for Mountain Valley MD licensees and for the company’s proprietary “Mountains Of…” brand. Public updates describe the following elements of its nutraceutical activities:
- Application of Quicksome™ technology to functional mushroom-based sublingual products under a license agreement with Circadian Wellness Corp., including products such as Eons Deeper Sleep and Eons Dialed, which the company states incorporate Quicksome™ technology.
- Development of additional Quicksome™ formulations for categories such as sleep, energy, immunity, appetite suppressant, lean metabolism, focus, stress and anxiety support, joint health, pain management, hematological health, nutritional support, hydration and performance.
- Use of Quicksome™ in proprietary formulations for specific client projects, including a fenugreek glycosides testosterone formulation and an opioid use disorder adjunct therapy project, as described in company business updates.
Mountain Valley MD reports that its “Mountains Of…” brand has obtained trademark protection in the United States for multiple product categories, including Sleep, Energy, Relief, Libido, and Lean, and that these formulations are available to distribution partners either under the company’s brand or as white-label products manufactured by its Lead Manufacturer.
Quicksol™ Technology and Soluvec™ 1%
In the husbandry animals and aquatic species segment, Mountain Valley MD describes applying its Quicksol™ technology to ivermectin to create a formulation referred to as Soluvec™ 1%. The company states that this formulation is designed to provide a safer and more effective solution for administration across husbandry animals and aquatic species, and that third-party validation has demonstrated stability at room and refrigerated temperatures.
Public disclosures indicate that the company’s commercialization strategy for Soluvec™ 1% is based on licensing the technology to regional partners rather than directly operating manufacturing facilities. For example, Mountain Valley MD reports an exclusive license agreement with a partner in Bangladesh to manufacture and distribute Soluvec™ 1% products in injectable and feed coating formats in exchange for royalties based on net sales. The company has also stated that it is exploring additional licensing opportunities in Latin America and other markets and has filed for patent protection for Soluvec™ in multiple jurisdictions outside the United States.
According to the company, peer-reviewed study data published in the journal Therapeutic Delivery support improved bioavailability, efficacy, and potential cost savings of Soluvec™ formulations compared to conventional ivermectin formulations.
Agrarius™ Agricultural Plant Signaling Technology
Mountain Valley MD’s agricultural business is centered on its role as a licensed reseller and exclusive distributor of the Agrarius™ plant signaling technology in specified territories. Under an Amended and Restated Supply and License Agreement with Agrarius Corp., the company reports holding exclusive rights to sell Agrarius™ in North America, Mexico, Central America, South America, and the Caribbean, while retaining non-exclusive rights outside this territory.
The company describes Agrarius™ as a certified organic product designed to activate plant defense mechanisms at the cellular level without the actual stress factor, with intended effects that include deeper root growth, optimized photosynthesis, improved water and nutrient use efficiency, and increased resistance to diseases and climate stress. Across multiple news releases, Mountain Valley MD reports that Agrarius™ has been tested across numerous crops and has demonstrated:
- Natural yield increases, with reported ranges that vary by crop and trial.
- Potential reductions in fertilizer usage where applied.
- Improved resilience to pests and environmental stress, including drought conditions.
The company highlights extensive trial programs in Latin America, including citrus, corn, sugarcane, soybeans, cotton, potatoes, and pasture grass, undertaken with third-party agronomy partners, universities, farmer networks, and agricultural organizations. It also reports a Performance Guarantee Program under which participating clients pay for Agrarius™ only if agreed performance thresholds are met, with Mountain Valley MD and Agrarius Corp. sharing the performance risk.
Vision and Application Areas
Mountain Valley MD repeatedly references a vision of “More Life” in its public communications. It states that it applies its technologies to advanced delivery of molecules for human and husbandry animal applications, including the development of products for pain management, weight loss, energy, focus, sleep, anxiety, and related wellness areas. In agriculture, the company positions its work with Agrarius™ as focused on generating positive impacts on crop yields and reducing fertilizer usage.
Across its lines of business, the company emphasizes licensing arrangements, trademarked brands, and partnerships with manufacturing, agronomy, and distribution partners as central to its operating approach.
Trading and Industry Context
Mountain Valley MD Holdings Inc. is referenced in public news as trading on the CSE under the symbol MVMD and on the OTCQB under the symbol MVMDF, with an additional listing reference on the FRA under the symbol 20MP. While the initial classification provided lists the industry as gold ore mining, the company’s own disclosures consistently describe its activities in biotechnology-related nutraceuticals, pharmaceutical formulation technologies, and agricultural plant signaling products rather than mineral extraction.
Stock Performance
More Life Company (MVMDF) closed at $0.0471 on August 20, 2026. In the 12 months to August 20, 2026, the price gained 229.4%.
See what a $1,000 investment in MVMDF was worth at its last close
MVMDF Metrics & Rankings
Price returns through August 20, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
More Life Company has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 3 with negative movement. Key topics include management, private placement. View all MVMDF news →
SEC Filings
Financial Highlights
We do not hold any annual figures for More Life Company yet, so there is nothing to show here.
Upcoming Events
Warrant expiry
Options vest 50%
Option vesting completion
Options expire
Option expiration
More Life Company has 5 upcoming scheduled events. The next event, "Warrant expiry", is scheduled for April 15, 2027 (in 146 days). 1 of them is a financing or capital event, such as a dividend or a debt maturity. Investors can track these dates to stay informed about potential catalysts that may affect the MVMDF stock price.
Short Interest History
Short interest in More Life Company (MVMDF) currently stands at 18.5 thousand shares, up 99.3% from the previous reporting period, representing 0.0% of the float. Since November 2025, short interest has increased by 6059.0%.
Days to Cover History
Days to cover for More Life Company (MVMDF) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 1.6 days.
MVMDF Company Profile & Sector Positioning
More Life Company (MVMDF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing MVMDF often look at related companies in the same sector, including BioNxt Solutions Inc (BNXTF), Healthy Extracts Inc (HYEX), Avicanna Inc (AVCNF), Panacea Life Science HLD (PLSH), and Cryomass Technologies Inc (CRYM). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MVMDF's relative position within its industry.